We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 19

79% more capital invested

Capital invested by funds: $1.25B → $2.24B (+$991M)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

23% more funds holding

Funds holding: 124 → 152 (+28)

18.42% more ownership

Funds ownership: 107.15% → 125.57% (+18%)

10% more call options, than puts

Call options by funds: $39.4M | Put options by funds: $35.7M

Holders
152
Holders Change
+28
Holders Change %
+22.58%
% of All Funds
3.48%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
47
Increased
54
Reduced
39
Closed
19
Calls
$39.4M
Puts
$35.7M
Net Calls
+$3.62M
Net Calls Change
-$7.32M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.3M
2
BBA
Baker Bros. Advisors
New York
+$44.6M
3
EAM
Eagle Asset Management
Florida
+$41.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$34.7M
5
BM
Bridger Management
New York
+$29M

Top Sellers

1
CC
Carlson Capital
Texas
-$26.2M
2
Franklin Resources
Franklin Resources
California
-$26.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$15.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$15M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
$1.37M +$1.13M +49,780 New
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$1.36M +$143K +6,322 +15%
BGIM
78
Brandywine Global Investment Management
Pennsylvania
$1.33M -$488K -21,508 -31%
Susquehanna International Group
79
Susquehanna International Group
Pennsylvania
$1.24M -$4.87M -214,557 -83%
Wolverine Trading
80
Wolverine Trading
Illinois
$1.22M +$1M +44,150 New
OC
81
Oppenheimer & Co
New York
$1.21M +$996K +43,899 New
PA
82
Pinnacle Associates
New York
$1.21M +$739K +32,560 +293%
PCM
83
Prelude Capital Management
New York
$1.13M -$255K -11,253 -22%
BRWA
84
B. Riley Wealth Advisors
Florida
$1.12M -$1.16M -51,200 -56%
CPC
85
Congress Park Capital
New York
$1.08M -$168K -7,400 -16%
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.08M +$121K +5,349 +16%
MS
87
Maven Securities
Jersey
$1.03M +$845K +37,244 New
AC
88
Athanor Capital
New York
$966K +$794K +35,000 New
AIG
89
American International Group
New York
$958K +$93.2K +4,107 +13%
MFIM
90
Mesirow Financial Investment Management
Illinois
$922K -$11K -486 -1%
HI
91
HBK Investments
Texas
$893K -$60.1K -2,649 -8%
TRSOTSOK
92
Teachers Retirement System of the State of Kentucky
Kentucky
$880K +$724K +31,900 New
GXMC
93
Global X Management Company
New York
$864K +$710K +31,306 New
Barclays
94
Barclays
United Kingdom
$839K +$426K +18,792 +162%
SI
95
Sofinnova Investments
California
$832K +$684K +30,133 New
RJA
96
Raymond James & Associates
Florida
$799K +$657K +28,944 New
VRS
97
Virginia Retirement Systems
Virginia
$792K +$56.7K +2,500 +10%
Group One Trading
98
Group One Trading
Illinois
$775K -$685K -30,210 -52%
BA
99
Boston Advisors
Massachusetts
$763K +$627K +27,655 New
ADEF
100
Adams Diversified Equity Fund
Maryland
$726K +$597K +26,300 New
2 3
4
5 6

HRTX Hedge Fund Activity: Q1 2018 in Review

152 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2018, worth a combined $2.24B — up 79% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new HRTX positions and 19 closed out — a net gain of 28 holders — while 54 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $49.3M. The largest seller was Carlson Capital, cutting an estimated $26.2M.

  • 152 institutional investors held Heron Therapeutics (HRTX) as of Q1 2018, up from 124 in Q4 2017.
  • Funds reported $2.24B of Heron Therapeutics stock for Q1 2018, up 79% quarter-over-quarter.
  • 47 funds opened new Heron Therapeutics positions in Q1 2018 and 19 closed out, a net change of +28 holders.
  • The largest Heron Therapeutics buyer in Q1 2018 was Wellington Management Group, an estimated $49.3M added.
  • The largest Heron Therapeutics seller in Q1 2018 was Carlson Capital, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2018.